These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 18392327)

  • 1. Glycaemic control improves fibrin network characteristics in type 2 diabetes - a purified fibrinogen model.
    Pieters M; Covic N; van der Westhuizen FH; Nagaswami C; Baras Y; Toit Loots D; Jerling JC; Elgar D; Edmondson KS; van Zyl DG; Rheeder P; Weisel JW
    Thromb Haemost; 2008 Apr; 99(4):691-700. PubMed ID: 18392327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects.
    Pieters M; Covic N; Loots du T; van der Westhuizen FH; van Zyl DG; Rheeder P; Jerling JC; Weisel JW
    Thromb Haemost; 2006 Nov; 96(5):623-9. PubMed ID: 17080220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation.
    Pieters M; van Zyl DG; Rheeder P; Jerling JC; Loots du T; van der Westhuizen FH; Gottsche LT; Weisel JW
    Thromb Res; 2007; 120(3):439-46. PubMed ID: 17156827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus.
    Dunn EJ; Philippou H; Ariëns RA; Grant PJ
    Diabetologia; 2006 May; 49(5):1071-80. PubMed ID: 16538489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of type 2 diabetes on fibrin structure and function.
    Dunn EJ; Ariëns RA; Grant PJ
    Diabetologia; 2005 Jun; 48(6):1198-206. PubMed ID: 15864538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism.
    Martinez MR; Cuker A; Mills AM; Crichlow A; Lightfoot RT; Chernysh IN; Nagaswami C; Weisel JW; Ischiropoulos H
    Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(5):L397-404. PubMed ID: 24414255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
    Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
    Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin Fiber Stiffness Is Strongly Affected by Fiber Diameter, but Not by Fibrinogen Glycation.
    Li W; Sigley J; Pieters M; Helms CC; Nagaswami C; Weisel JW; Guthold M
    Biophys J; 2016 Mar; 110(6):1400-10. PubMed ID: 27028649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3.
    Hess K; Alzahrani SH; Mathai M; Schroeder V; Carter AM; Howell G; Koko T; Strachan MW; Price JF; Smith KA; Grant PJ; Ajjan RA
    Diabetologia; 2012 Apr; 55(4):1103-13. PubMed ID: 21918806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis.
    Collet JP; Moen JL; Veklich YI; Gorkun OV; Lord ST; Montalescot G; Weisel JW
    Blood; 2005 Dec; 106(12):3824-30. PubMed ID: 16091450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.
    Greenhalgh KA; Strachan MW; Alzahrani S; Baxter PD; Standeven KF; Storey RF; Ariens RA; Grant PJ; Price JF; Ajjan RA
    Thromb Haemost; 2017 Jan; 117(2):295-302. PubMed ID: 27929198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis.
    Siebenlist KR; Mosesson MW
    J Biol Chem; 1994 Nov; 269(45):28414-9. PubMed ID: 7961782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
    Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
    Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpretation and Validation of Maximum Absorbance Data Obtained from Turbidimetry Analysis of Plasma Clots.
    Pieters M; Guthold M; Nunes CM; de Lange Z
    Thromb Haemost; 2020 Jan; 120(1):44-54. PubMed ID: 31752041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Glycation and Presence of Glucose Impair Fibrin Polymerization-An In Vitro Study of Isolated Fibrinogen and Plasma from Patients with Diabetes Mellitus.
    Luzak B; Boncler M; Kosmalski M; Mnich E; Stanczyk L; Przygodzki T; Watala C
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32517350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance of gammaA/gamma' fibrin clots to fibrinolysis.
    Falls LA; Farrell DH
    J Biol Chem; 1997 May; 272(22):14251-6. PubMed ID: 9162058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function.
    Standeven KF; Grant PJ; Carter AM; Scheiner T; Weisel JW; Ariëns RA
    Circulation; 2003 May; 107(18):2326-30. PubMed ID: 12707238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Amadori-modified plasma proteins in type 2 diabetes and the effect of short-term intensive insulin treatment.
    Jaleel A; Halvatsiotis P; Williamson B; Juhasz P; Martin S; Nair KS
    Diabetes Care; 2005 Mar; 28(3):645-52. PubMed ID: 15735202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biophysical Mechanisms Mediating Fibrin Fiber Lysis.
    Hudson NE
    Biomed Res Int; 2017; 2017():2748340. PubMed ID: 28630861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.